2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
https://doi.org/10.15829/1560-4071-2020-3826
Abstract
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
About the Authors
Francois Mach
Geneva University Hospital
Switzerland
Switzerland
Cardiology Department.
4 Gabrielle-Perret-Gentil, 1211 Geneva, Tel: +41 223 727 192, Fax: +41 223 727 229
Colin Baigent
University of Oxford
United Kingdom
United Kingdom
Nuffield Department of Population Health.
Richard Doll Building, Roosevelt Drive, Oxford OX3 7LF United Kingdom, Tel: +44 1865 743 741, Fax: +44 1865 743 985
Alberico L. Catapano
University of Milan
Italy
Italy
Department of Pharmacological and Biomolecular Sciences.
Via Balzaretti, 9, 20133 Milan, and Multimedica IRCCS, Milan, Tel: +39 02 5031 8401, Fax: +39 02 5031 8386
Konstantinos C. Koskinas
Switzerland
Manuela Casula
Italy
Lina Badimon
Spain
M. John Chapman
France
Guy G. De Backer
Belgium
Victoria Delgado
Netherlands
Brian A. Ference
United Kingdom
Ian M. Graham
Ireland
Alison Halliday
United Kingdom
Ulf Landmesser
Germany
Borislava Mihaylova
United Kingdom
Terje R. Pedersen
Norway
Gabriele Riccardi
Italy
Dimitrios J. Richter
Greece
Marc S. Sabatine
United States
Marja-Riitta Taskinen
Finland
Lale Tokgozoglu
Turkey
Olov Wiklund
Sweden
Review
For citations:
Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L., Chapman M.J., De Backer G.G., Delgado V., Ference B.A., Graham I.M., Halliday A., Landmesser U., Mihaylova B., Pedersen T.R., Riccardi G., Richter D.J., Sabatine M.S., Taskinen M., Tokgozoglu L., Wiklund O. 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk. Russian Journal of Cardiology. 2020;25(5):3826. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3826
Views:
19568
Email this article 